Randomized Trial of Perioperative Probiotics Among Patients Undergoing Major Abdominal Operation

Abstract

Perioperative use of VSL#3 probiotic did not affect 30-day composite end point of mortality, readmission, and infection rate. A significantly higher readmission rate was observed among those exposed to probiotics. Additional studies remain warranted.